| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/23/2002 | CA2193149C Cationic therapuetic agents and delivery systems |
| 04/23/2002 | CA2099771C Liposomal-polyene preliposomal powder and method for its preparation |
| 04/23/2002 | CA2072148C Tissue moisturizing composition and method |
| 04/23/2002 | CA2067395C Antimetastatically acting agents |
| 04/18/2002 | WO2002031498A2 Protecting therapeutic compositions from host-mediated inactivation |
| 04/18/2002 | WO2002031142A2 Antisense nucleic acid against alphav integrin |
| 04/18/2002 | WO2002031109A2 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 04/18/2002 | WO2002031025A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 04/18/2002 | WO2002030957A1 Peptide-based gemini surfactant compounds facilitating the transfer into cells |
| 04/18/2002 | WO2002030485A1 Embolic materials |
| 04/18/2002 | WO2002030474A1 Kit for intraperitoneal administration and extracorpeal removal of a drug |
| 04/18/2002 | WO2002030473A1 Targeted therapeutic agents |
| 04/18/2002 | WO2002030472A2 Compositions for release of radiosensitizers, and methods of making and using the same |
| 04/18/2002 | WO2002030470A1 Methods and compositions for nucleic acid delivery |
| 04/18/2002 | WO2002030469A2 Beta-lactam antibiotic-polysaccharide complex |
| 04/18/2002 | WO2002030468A1 Complexes for transferring nucleic acids into cells |
| 04/18/2002 | WO2002030467A2 Pharmaceutical composition containing honey for the treatment of wounds |
| 04/18/2002 | WO2002030466A2 Pharmaceutical applications of hydrotropic agents, polymers thereof, and hydrogels thereof |
| 04/18/2002 | WO2002030465A2 Compositions that inhibit proliferation of cancer cells |
| 04/18/2002 | WO2002030463A2 Reduced-viscosity concentrated protein formulations |
| 04/18/2002 | WO2002030460A2 Therapeutic antibodies |
| 04/18/2002 | WO2002030456A1 Targeting drug/gene carriers to irradiated tissue |
| 04/18/2002 | WO2002030437A1 Citrus composition for hygiene, care or protection of teats |
| 04/18/2002 | WO2002030424A1 Modified prodrug forms of ap/amp |
| 04/18/2002 | WO2002030417A1 Medicinal suspensions containing branched amino acids |
| 04/18/2002 | WO2002030416A1 Medicinal suspensions containing branched amino acids |
| 04/18/2002 | WO2002030414A1 Compositions comprising modafinil compounds |
| 04/18/2002 | WO2002030413A1 Pharmaceutical solutions of modafinil compounds |
| 04/18/2002 | WO2002030409A2 Methods for the treatment of a traumatic central nervous system injury |
| 04/18/2002 | WO2002030398A2 Delayed release pharmaceutical formulations |
| 04/18/2002 | WO2002030397A1 Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors |
| 04/18/2002 | WO2002030396A1 Medication delivery devices |
| 04/18/2002 | WO2002030395A1 Topical antibiotic composition for treatment of eye infection |
| 04/18/2002 | WO2002030394A2 Medicinal aerosol formulations |
| 04/18/2002 | WO2002030393A2 Polymeric delivery formulations of leuprolide with improved efficacy |
| 04/18/2002 | WO2002030391A2 Method for determining the release of a peptide from a sustained release polylactide formulation |
| 04/18/2002 | WO2002030389A1 Novel tiotropium-containing inhalation powder |
| 04/18/2002 | WO2002030213A1 Encased food product with contrasting components |
| 04/18/2002 | WO2002011740A3 'slow release' pharmaceutical compositions comprising lithium carbonate |
| 04/18/2002 | WO2002011697A8 A method of preparing a pharmaceutical composition |
| 04/18/2002 | WO2002009814A3 New use of lipase inhibitors |
| 04/18/2002 | WO2002009763A3 Transdermal drug delivery system |
| 04/18/2002 | WO2002009679A3 Use of 13-cis retinoic acid for the treatment of emphysema |
| 04/18/2002 | WO2002007738A8 Combinations of chitosan and psyllium for synergistic adsorption of triglyceride and cholesterol |
| 04/18/2002 | WO2002004570A3 Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
| 04/18/2002 | WO2002000201A3 Method for preparing a composition |
| 04/18/2002 | WO2001091732A3 Medicament for combating respiratory depression |
| 04/18/2002 | WO2001087272A3 Encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 04/18/2002 | WO2001087265A3 Pharmaceutical form of administration for peptides, methods for its production and use |
| 04/18/2002 | WO2001085139A3 Semi-solid delivery vehicle and pharmaceutical compositions |
| 04/18/2002 | WO2001085137A3 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| 04/18/2002 | WO2001085136A3 Phospholipid-based powders for drug delivery |
| 04/18/2002 | WO2001085099A3 Polymeric delivery and release systems for oral care actives |
| 04/18/2002 | WO2001079114A3 Salt comprising more than 95 wt. % of sodium chloride, use and preparation method thereof and method for measuring salt water content |
| 04/18/2002 | WO2001078682A3 Sustained release drug compositions |
| 04/18/2002 | WO2001072289A3 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
| 04/18/2002 | WO2001070288A3 Thermoreversible polymers for delivery and retention of osteoinductive proteins |
| 04/18/2002 | WO2001068075A3 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 04/18/2002 | WO2001060377A3 Methods for treatment of lysosomal storage diseases using biphosphonates |
| 04/18/2002 | WO2001060335A3 Delivery systems using preformed biodegradable polymer compositions and methods |
| 04/18/2002 | WO2001059087A3 Compositions for transfecting nucleic acids and their use |
| 04/18/2002 | WO2001043935A3 Injection molding method for neutral and acidic-group containing (meth)acrylate copolymers |
| 04/18/2002 | WO2001032684A3 Method for linking molecular substances based on the affinity of the proline-rich amino acid sequences and protein domains of type ww |
| 04/18/2002 | WO2000070341A9 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 04/18/2002 | WO2000067793A9 Death domain containing receptor 4 |
| 04/18/2002 | WO2000061177A9 Composition based on oppositely-charged polypeptides |
| 04/18/2002 | US20020045940 Methods, instruments and materials for chondrocyte cell transplantation |
| 04/18/2002 | US20020045745 Washing starch containing more than 85% amylopectin in order to remove surface-localized proteins, lipids and endotoxins; molecular weight reduction by shearing |
| 04/18/2002 | US20020045736 Anticarcinogenic agents for use in the treatment of cancer |
| 04/18/2002 | US20020045668 Compositions for sustained release of analgesic agents, and methods of making and using the same |
| 04/18/2002 | US20020045665 Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| 04/18/2002 | US20020045662 Stable gabapentin having pH within a controlled range |
| 04/18/2002 | US20020045646 Pharmaceutical preparations comprising substituted benzimidazole proton pump inhibitors with fast acting buffer; gastric acid stability for enteral administration |
| 04/18/2002 | US20020045604 Formulations for treating or preventing mucositis |
| 04/18/2002 | US20020045601 Ophthalmic compositions |
| 04/18/2002 | US20020045596 Aging resistance; oxidation resistance |
| 04/18/2002 | US20020045582 Stabilized protein crystals formulations containing them and methods of making them |
| 04/18/2002 | US20020045573 Dithiocarbamates linked to the surface of a non-immunogenic, non-targeting macromolecule other than an antibody (e.g., albumin protein); treating cerebral stroke and other ischemia/reperfusion injury |
| 04/18/2002 | US20020045571 Reduced-viscosity concentrated protein formulations |
| 04/18/2002 | US20020045263 Biodegradable particles for use in time release agents and gene therapy |
| 04/18/2002 | US20020045208 Nucleotide sequences which code polypeptides for use in treatment of autoimmune diseases, allergies and tumors |
| 04/18/2002 | US20020044992 Calcium compound and an acidulant; pH of the composition is from 3.5 to 4.5; having reduced tooth erosion characteristics, especially acid beverages such as fruit juice |
| 04/18/2002 | US20020044980 Nutritional suplement based on blackcurrent seed oil |
| 04/18/2002 | US20020044975 Colon-specific drug release system |
| 04/18/2002 | US20020044973 Microparticles and their use in cancer treatment |
| 04/18/2002 | US20020044972 Nucleic acid or oligonucleotide and a positively charged, aminated ethylene oxide-propylene oxide block copolymer |
| 04/18/2002 | US20020044970 Monolayer sugar-coated tablet and process for preparation thereof |
| 04/18/2002 | US20020044967 Sustained release preparations |
| 04/18/2002 | US20020044966 Pharmaceutical formulations containing an opioid and an alpha-agonist |
| 04/18/2002 | US20020044965 Side effect profile reduction |
| 04/18/2002 | US20020044959 Biomolecule carrier bearing molecules that bind to a cellular adhesion molecule expressed on endothelial cell |
| 04/18/2002 | US20020044958 Disaccharide protector; frozen; preserved for longer than one year; shows excellent restoration ability in water |
| 04/18/2002 | US20020044956 Microbiocides, antiinflammatories, antihistamines and mucoadhesives |
| 04/18/2002 | US20020044950 Recombinant toxin fragments |
| 04/18/2002 | US20020044937 Where the protein binds to T-cell cell surface protein, and that complex with nucleic acids, for transporting nucleic acids into human or animal cells which express the T-cell surface protein; antisense therapy, HIV therapy |
| 04/18/2002 | US20020044922 Recombinant phages |
| 04/18/2002 | US20020044921 Pegylated interleukin-10 |
| 04/18/2002 | US20020044909 Cyanine dye bioconjugates with bioactive molecules for diagnosis and therapy, particularly for visualization and detection of tumors |
| 04/18/2002 | DE10060550C1 Transdermal therapeutic system for administration of oxybutynin, especially for treatment of bladder dysfunction, having two-phase matrix layer of active agent-containing droplets dispersed in adhesive |
| 04/18/2002 | CA2751188A1 Reduced-viscosity concentrated protein formulations |